Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Nurix Therapeutics, Inc. NRIX

Set alert

Price alert · NRIX

All alert types
25.70 USD -1.10 -4.10%

At close · Nov 2

25.74 +0.04 +0.16%

After hours · Nov 2, 4:55 PM ET

Bid
25.68 × 2
Ask
25.69 × 2
25.53 Day range 26.96
11.67 52-week range 28.23
YTD
+35.48%
1 year
+98.61%
Open
26.75
Prev close
26.80
Mkt cap
2.81B
Vol
2.35M
Avg vol
1.72M
EPS
2.43
P/E
10.58
Div yield
0.00%
More statistics
Low
25.53
High
26.96
Forward P/E
-20.15
Beta
1.78
Short ratio
10.30
Inst. own
111.03%
Dividend
0.00
Ex-div date
Earnings
Jan 27, 2027
50-d avg
24.98
200-d avg
20.18
1y target
34.50

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 12, 2026Earnings: 4.73; estimate -0.60091; surprise 887.14%
  • Oct 13, 2026Rating: Needham · Buy → Buy
  • Oct 13, 2026Rating: Baird · Outperform → Outperform
  • Oct 13, 2026Rating: Truist Securities · Buy → Buy
  • Oct 13, 2026Rating: Oppenheimer · Outperform → Outperform
  • Oct 13, 2026Rating: RBC Capital · Outperform → Outperform
  • Oct 16, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (12)
NameDateAgo
SMA: BullishOct 20, 20261 week ago
SMA: BullishOct 15, 20262 weeks ago
MACD: Buy SignalOct 14, 20262 weeks ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 16, 20261 month ago
SMA: BearishSep 15, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BullishSep 4, 20261 month ago
SMA: BearishSep 3, 20262 months ago
MACD: Sell SignalAug 24, 20262 months ago
RSI: OverboughtAug 10, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago

Financial health

Altman Z-Score

9.10 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 2

Valuation

P/E -5.5×
FY 2018: -32.2×FY 2019: -33.9×FY 2020: -15.4×FY 2021: -10.6×FY 2022: -3.3×FY 2023: -2.3×FY 2024: -7.7×FY 2025: -5.5×
FY 2018 5y median -5.5× FY 2025
P/S 17.5×
FY 2018: 8.2×FY 2019: 23.7×FY 2020: 37.5×FY 2021: 41.6×FY 2022: 15.6×FY 2023: 4.4×FY 2024: 27.2×FY 2025: 17.5×
FY 2018 5y median 17.5× FY 2025
P/B 2.7×
FY 2018: -8.3×FY 2019: -12.8×FY 2020: 2.3×FY 2021: 3.6×FY 2022: 2.0×FY 2023: 1.7×FY 2024: 2.8×FY 2025: 2.7×
FY 2018 5y median 2.7× FY 2025
P/FCF -5.6×
FY 2018: -9.2×FY 2019: -703×FY 2020: -144×FY 2021: -13.7×FY 2022: -3.5×FY 2023: -3.8×FY 2024: -8.2×FY 2025: -5.6×
FY 2018 5y median -5.6× FY 2025
EV/EBITDA -5.2×
FY 2018: -41.6×FY 2019: -35.4×FY 2020: -8.7×FY 2021: -10.5×FY 2022: -3.2×FY 2023: -2.4×FY 2024: -7.9×FY 2025: -5.2×
FY 2018 5y median -5.2× FY 2025
EV/Sales 15.2×
FY 2018: 7.5×FY 2019: 22.6×FY 2020: 30.8×FY 2021: 39.3×FY 2022: 14.2×FY 2023: 4.1×FY 2024: 25.7×FY 2025: 15.2×
FY 2018 5y median 15.2× FY 2025
FCF Yield -18.0%
FY 2018: -10.9%FY 2019: -0.1%FY 2020: -0.7%FY 2021: -7.3%FY 2022: -28.6%FY 2023: -26.6%FY 2024: -12.3%FY 2025: -18.0%
FY 2018 5y median -18.0% FY 2025

Profitability

Gross Margin 77.5%
FY 2018: -8.2%FY 2019: -44.7%FY 2020: -273.1%FY 2021: -291.4%FY 2022: -377.6%FY 2023: -145.7%FY 2024: -306.3%FY 2025: 77.5%
FY 2018 5y median -291.4% FY 2025
Operating Margin -340.2%
FY 2018: -26.0%FY 2019: -71.5%FY 2020: -364.7%FY 2021: -396.3%FY 2022: -476.0%FY 2023: -201.4%FY 2024: -390.5%FY 2025: -340.2%
FY 2018 5y median -390.5% FY 2025
Net Margin -314.9%
FY 2018: -25.2%FY 2019: -69.7%FY 2020: -242.7%FY 2021: -393.9%FY 2022: -466.9%FY 2023: -187.0%FY 2024: -354.9%FY 2025: -314.9%
FY 2018 5y median -354.9% FY 2025
ROE -49.1%
FY 2018: 25.6%FY 2019: 37.6%FY 2020: -14.9%FY 2021: -34.2%FY 2022: -59.4%FY 2023: -71.8%FY 2024: -36.7%FY 2025: -49.1%
FY 2018 5y median -49.1% FY 2025
ROIC -47.3%
FY 2018: -77.5%FY 2019: -79.7%FY 2020: -12.5%FY 2021: -28.5%FY 2022: -52.3%FY 2023: -56.2%FY 2024: -36.6%FY 2025: -47.3%
FY 2018 5y median -47.3% FY 2025
ROA -38.4%
FY 2018: -20.8%FY 2019: -49.3%FY 2020: -10.9%FY 2021: -24.6%FY 2022: -43.3%FY 2023: -40.5%FY 2024: -28.9%FY 2025: -38.4%
FY 2018 5y median -38.4% FY 2025

Growth (YoY)

Revenue 54.0%
FY 2018: 0.0%FY 2019: -16.9%FY 2020: -42.7%FY 2021: 66.9%FY 2022: 29.8%FY 2023: 99.3%FY 2024: -29.1%FY 2025: 54.0%
FY 2018 FY 2025
Operating Income -34.1%
FY 2018: 0.0%FY 2019: -128.3%FY 2020: -192.2%FY 2021: -81.4%FY 2022: -56.0%FY 2023: 15.7%FY 2024: -37.4%FY 2025: -34.1%
FY 2018 FY 2025
EPS (diluted) -5.9%
FY 2018: 0.0%FY 2019: 5.1%FY 2020: -392.9%FY 2021: 1.1%FY 2022: -35.9%FY 2023: 28.6%FY 2024: -8.7%FY 2025: -5.9%
FY 2018 FY 2025
Free Cash Flow -44.9%
FY 2018: 0.0%FY 2019: 96.8%FY 2020: -341.2%FY 2021: -1843.1%FY 2022: -91.1%FY 2023: 47.8%FY 2024: -102.6%FY 2025: -44.9%
FY 2018 FY 2025

Financial Health

Current Ratio 7.0×
FY 2018: 1.2×FY 2019: 2.4×FY 2020: 6.7×FY 2021: 4.7×FY 2022: 4.5×FY 2023: 3.4×FY 2024: 6.5×FY 2025: 7.0×
FY 2018 5y median 4.7× FY 2025
Quick Ratio 7.0×
FY 2018: 1.2×FY 2019: 2.4×FY 2020: 6.7×FY 2021: 4.7×FY 2022: 4.5×FY 2023: 3.4×FY 2024: 6.5×FY 2025: 7.0×
FY 2018 5y median 4.7× FY 2025
Debt / Equity 0.1×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.8×
FY 2018: 3.8×FY 2019: 1.8×FY 2020: 1.9×FY 2021: 0.6×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.5×FY 2025: 0.8×
FY 2018 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-11-30